These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22509368)

  • 41. Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation.
    Li Y; Qu X; Qu J; Zhang Y; Liu J; Teng Y; Hu X; Hou K; Liu Y
    Cancer Lett; 2009 Nov; 284(2):208-15. PubMed ID: 19457607
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.
    Liontas A; Yeger H
    Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.
    Lai PB; Chi TY; Chen GG
    Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aciculatin induces p53-dependent apoptosis via MDM2 depletion in human cancer cells in vitro and in vivo.
    Lai CY; Tsai AC; Chen MC; Chang LH; Sun HL; Chang YL; Chen CC; Teng CM; Pan SL
    PLoS One; 2012; 7(8):e42192. PubMed ID: 22912688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage.
    Zhang A; Zhou N; Huang J; Liu Q; Fukuda K; Ma D; Lu Z; Bai C; Watabe K; Mo YY
    Cell Res; 2013 Mar; 23(3):340-50. PubMed ID: 23208419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MDM2 antagonist can inhibit tumor growth in hepatocellular carcinoma with different types of p53 in vitro.
    Wang J; Zheng T; Chen X; Song X; Meng X; Bhatta N; Pan S; Jiang H; Liu L
    J Gastroenterol Hepatol; 2011 Feb; 26(2):371-7. PubMed ID: 21261729
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells.
    Tanigawa S; Fujii M; Hou DX
    Biosci Biotechnol Biochem; 2008 Mar; 72(3):797-804. PubMed ID: 18323654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Involvement of p53, nuclear factor kappaB and Fas/Fas ligand in induction of apoptosis and cell cycle arrest by saikosaponin d in human hepatoma cell lines.
    Hsu YL; Kuo PL; Chiang LC; Lin CC
    Cancer Lett; 2004 Sep; 213(2):213-21. PubMed ID: 15327837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Platinum-(IV)-derivative satraplatin induced G2/M cell cycle perturbation via p53-p21(waf1/cip1)-independent pathway in human colorectal cancer cells.
    Kalimutho M; Minutolo A; Grelli S; Federici G; Bernardini S
    Acta Pharmacol Sin; 2011 Nov; 32(11):1387-96. PubMed ID: 21927014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel cytarabine analog evokes synthetic lethality by targeting MK2 in p53-deficient cancer cells.
    Song J; Yu J; Jeong LS; Lee SK
    Cancer Lett; 2021 Jan; 497():54-65. PubMed ID: 33075425
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biotechnological Applications for the Sustainable Use of Marine By-products: In Vitro Antioxidant and Pro-apoptotic Effects of Astaxanthin Extracted with Supercritical CO
    Messina CM; Manuguerra S; Renda G; Santulli A
    Mar Biotechnol (NY); 2019 Aug; 21(4):565-576. PubMed ID: 31079239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
    Gong EY; Shin YJ; Hwang IY; Kim JH; Kim SM; Moon JH; Shin JS; Lee DH; Hur DY; Jin DH; Hong SW; Lee WK; Lee WJ
    Toxicol Lett; 2016 Sep; 258():126-133. PubMed ID: 27339904
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
    John K; Alla V; Meier C; Pützer BM
    Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
    Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
    Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel ruthenium complex with xanthoxylin induces S-phase arrest and causes ERK1/2-mediated apoptosis in HepG2 cells through a p53-independent pathway.
    de Carvalho NC; Neves SP; Dias RB; Valverde LF; Sales CBS; Rocha CAG; Soares MBP; Dos Santos ER; Oliveira RMM; Carlos RM; Nogueira PCL; Bezerra DP
    Cell Death Dis; 2018 Jan; 9(2):79. PubMed ID: 29362398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The p53-independent induction of apoptosis in breast cancer cells in response to proteasome inhibitor bortezomib.
    Yerlikaya A; Okur E; Ulukaya E
    Tumour Biol; 2012 Oct; 33(5):1385-92. PubMed ID: 22477712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
    Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
    Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NFkappaB, c-fos/c-jun, and p53 proteins.
    Liu GY; Frank N; Bartsch H; Lin JK
    Mol Carcinog; 1998 Aug; 22(4):235-46. PubMed ID: 9726816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular characterization of oncostatin M-induced growth arrest of MCF-7 cells expressing a temperature-sensitive mutant of p53.
    Li C; Shridhar K; Liu J
    Breast Cancer Res Treat; 2003 Jul; 80(1):23-37. PubMed ID: 12889596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ROR agonist hampers the proliferation and survival of postactivated CD8
    Cai Z; Ishibashi T; Kozai M; Mita H; Wang S; Takada K; Inaba M
    Immunol Cell Biol; 2021 Mar; 99(3):288-298. PubMed ID: 32940916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.